Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hyperthermia × Folfox protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 20 Neoplasm Metastasis 6 Stomach Neoplasms 5 Rectal Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Hepatocellular 4 Cholangiocarcinoma 3 Carcinoma, Non-Small-Cell Lung 3 Adenocarcinoma Of Esophagus 3 Recurrence 2 Neoplastic Cells, Circulating 2 Neoplasms 2 Gastrointestinal Neoplasms 2 Biliary Tract Neoplasms 2 Adenocarcinoma 2 Unresectable Metastatic Colorectal Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Oligometastatic Gastric Adenocarcinoma 1 Neoplasms, Second Primary 1 Neoplasm, Residual 1 Margins of Excision 1 Lung Neoplasms 1 Locally-advanced Rectal Cancer 1 Locally Advanced Colorectal Carcinoma 1 Hyperthermia 1 Gastroesophageal Junction Adenocarcinoma 1 Gastroesophageal Adenocarcinoma 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1

Interventions

Diathermy 7 Radiotherapy 5 Surgical Procedures, Operative 2 Drug Therapy 2 tislelizumab 1 anlotinib 1 Solutions 1 Patient Reported Outcome Measures 1 Immunotherapy 1 Immune Checkpoint Inhibitors 1 Ifosfamide 1 Hyperthermia, Induced 1 Hydrogen Peroxide 1 Folfox protocol 1 Fluorouracil 1 Doxorubicin 1 Dacarbazine 1 Consolidation Chemotherapy 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06831981 2025-02-18

ARO 2024-13

University Hospital Tuebingen

Phase NA Recruiting

Gastrointestinal

Hyperthermia, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡